Suchergebnisse
EAT Bets Big on Chicken Sandwich Launch as a New Growth Lever
Brinker International, Inc. EAT is leaning into menu innovation to sustain its growth momentum. After posting strong same-store sales and steady traffic gains at Chili’s, the company is now focusing
Mama's Creations Q4 Earnings on Deck: What Should Investors Expect?
Mama’s Creations, Inc. MAMA is likely to witness top and bottom-line growth when it reports fourth-quarter fiscal 2026 earnings on April 14. The Zacks Consensus Estimate for revenues is pegged at
Lumen Focuses on EBITDA Recovery: Will Strategic Efforts Pay Off?
Lumen Technologies LUMN is in an important phase of its turnaround, with management targeting adjusted EBITDA inflection in 2026 after a period of sustained pressure. For 2026, adjusted EBITDA is
Petrobras Reclaims Full Control of Campos Basin Assets With $450M Deal
Petróleo Brasileiro S.A. - Petrobras PBR has taken a significant step in strengthening its upstream portfolio by signing agreements to acquire the remaining 50% stake in the Tartaruga Verde field
Ovintiv Stock Climbs 48% in 6 Months: Should You Buy or Hold for Now?
Over the past six months, Ovintiv Inc. OVV has clearly outperformed both its industry and the broader sector, as reflected in the chart below. OVV delivered a gain of approximately 47.7%
General Mills Omnichannel Strategy: Growth Catalyst Ahead?
General Mills, Inc. GIS is increasingly positioning omnichannel execution as a central pillar of the “Remarkable Experience” framework, underscoring its role in driving more consistent consumer
CAT Holds Dividend Steady For Now: Is a Hike Around the Corner?
Caterpillar Inc. CAT has kept its quarterly dividend unchanged at $1.51 per share so far this year, with the next payout scheduled for May 19, 2025.
Caterpillar has paid a cash dividend every year
Shell Accelerates LNG Supplies to India Amid West Asia Disruptions
Shell plc SHEL, a British multinational oil and gas company, has rapidly expanded liquefied natural gas (“LNG”) supplies to India, positioning itself as a critical stabilizing force in the country’s
Three Best Genomics Stocks for Your Portfolio in 2026
An updated edition of the Feb. 20, 2026, article.
Genomics involves a thorough study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). It involves understanding how genes
Pre-Markets Down as U.S. Sets Blockade at Hormuz
Monday, April 13th, 2026We start a new trading week with plenty on our calendar — hopefully which will offer some new market narratives outside the happenings at the Strait of Hormuz and its effect
APLD's Losses Continue Despite Growth Push: Hold or Fold the stock?
Applied Digital APLD shares are down 5.5% since the company reported its third-quarter fiscal 2026 results on April 8, 2026. The decline is notable given that revenues of $126.6 million surged
RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data
Revvity, Inc. RVTY announced the launch of Signals BioDesign, a cloud-based molecular cloning platform, under its Revvity Signals Software division. Designed for biotech and pharmaceutical R&D
This is Why Phillips Edison & Company, Inc. (PECO) is a Great Dividend Stock
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
Avnet (AVT) Could Be a Great Choice
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is
Why First United Corporation (FUNC) is a Great Dividend Stock Right Now
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is
Why Maximus (MMS) is a Top Dividend Stock for Your Portfolio
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
Replimune Group’s REPL share price is down 63% in the pre-market hours today after the company announced that the FDA has issued a second complete response letter (CRL) against its resubmitted
AMCR Enhances Sauce Packaging With Next-Gen Flip Top Closure Launch
Amcor plc AMCR announced the launch of its 55 mm Flava Flip Top Closure 38/400, a new closure targeting applications like mayonnaise, ketchup and sweet sauces. This new product is lightweight
Strategy Stock is Trading at a Discount: Should You Buy, Sell or Hold?
Strategy MSTR appears attractively valued, trading at a discount to both its industry and broader market benchmarks. The stock’s price-to-book (P/B) ratio of 0.97X is significantly lower than the


